ORBIMED ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G/A Report for C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: OrbiMed Capital LLC
Security: C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: CCCC
Shares outstanding: 70,539,394 shares
Disclosed Ownership: 4,655,600 shares
Ownership: 6.6%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 20:09:15 UTC
Date of event: 31 Mar 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
OrbiMed Advisors LLC	3.1%	2,174,700	0	2,174,700	/s/ Carl L. Gordon	Carl L. Gordon / Member
OrbiMed Capital LLC	6.6%	4,655,600	4,655,600	0	/s/ Carl L. Gordon	Carl L. Gordon / Member